For many patients, spinal surgery does not fully resolve chronic back pain — a condition known as Failed Back Surgery Syndrome (FBSS). Veterans face this challenge at elevated rates due to the cumulative physical demands of military service. Biologic disc repair, specifically intra-annular fibrin injection, may offer a non-surgical path forward for carefully evaluated candidates; outcomes vary by individual.

What Is Failed Back Surgery Syndrome?

Failed Back Surgery Syndrome is not a single diagnosis. It is a broad clinical term describing persistent or new back and leg pain that continues — or emerges — following spinal surgery. Symptoms may mirror those present before the operation, or they may be entirely different. In some patients, pain becomes more severe. FBSS may appear immediately after surgery or develop gradually over months or years.

Understanding why FBSS occurs is the first step toward identifying a meaningful treatment path.

Common Contributing Factors

• Incomplete diagnosis: If an annular tear was the true pain source rather than a herniation, removing the herniation may not resolve the underlying disc damage.
• Scar tissue formation: Post-surgical adhesions can form around nerve roots, creating new compression and chronic pain signals.
• Adjacent segment disease: Spinal fusion transfers mechanical stress to neighboring discs, potentially accelerating their degeneration and producing new symptoms.
• Nerve involvement: Direct nerve irritation or injury during surgery may produce persistent radicular symptoms.
• Hardware complications: Loosening, migration, or breakage of surgical implants can cause ongoing structural instability.
• Residual or recurring disc pathology: Even after surgery, annular tears may persist or develop at adjacent levels, sustaining the inflammatory cascade that drives discogenic pain.
• Psychosocial factors: Chronic pain and repeated treatment disappointments can intensify the experience of pain through central sensitization and psychological distress — a dimension that requires coordinated care.

For patients who have already endured surgery, extensive recovery, and ongoing pain, the emotional weight of FBSS can be profound. Many feel they have exhausted their options. That perception, while understandable, may not reflect the full range of available interventions.

Why Veterans Face Elevated FBSS Risk

Military service imposes extreme physical demands on the spine. Heavy load-bearing, repetitive impact from rucking and airborne operations, combat vehicle vibration, and acute trauma all accelerate disc degeneration. Research indicates that among ex-military parachutists, a large proportion show signs of lumbar disc degeneration on imaging. Veterans also report substantially higher rates of severe chronic pain compared with non-veteran populations, and low back pain represents one of the leading reasons active-duty personnel seek medical care.

When a veteran undergoes spinal surgery and still experiences debilitating pain, the consequences extend well beyond physical limitation. Employment, family engagement, sleep, and mental health can all be severely affected. Many veterans carry an additional burden: the cultural expectation of resilience can delay help-seeking and compound isolation.

Our clinical team recognizes these compounding factors. Veterans deserve an evaluation process that accounts for their service history, prior surgical record, and the full spectrum of available non-surgical options — not simply a recommendation for repeat surgery.

Expert Take

FBSS in veterans is rarely a single-mechanism problem. Service-related disc injury, post-surgical scarring, and adjacent-segment stress often coexist. A thorough workup that identifies each active pain generator — rather than targeting only the most obvious one — is what allows us to determine whether biologic disc repair is an appropriate candidate pathway for a given individual.

Why Standard Conservative Treatments Often Fall Short in FBSS

Patients with FBSS have typically already completed extended courses of physical therapy, chiropractic care, pain medications, and epidural steroid injections (ESIs). Each approach has genuine value in specific contexts, but none of them repairs structural disc damage.

• Physical therapy strengthens supporting musculature and improves movement patterns, but it cannot seal an annular tear or eliminate the inflammatory protein leak that irritates adjacent nerve tissue.
• Pain medications — including NSAIDs, muscle relaxants, and opioids — manage symptom perception without addressing the structural source. Long-term reliance carries dependency and side-effect risks.
• Epidural steroid injections target perineural inflammation and may provide meaningful short-term relief in some patients, but systematic reviews suggest limited durability for chronic discogenic pain. The underlying annular disruption continues to generate inflammatory signals once the steroid effect wanes.

When these modalities have already been exhausted — sometimes repeatedly — and the structural problem remains unaddressed, a different treatment philosophy is warranted. That is precisely where biologic disc repair enters the clinical conversation. For more on how non-surgical options compare, see our overview of 5 non-surgical disc treatments for chronic back pain.

Biologic Disc Repair: Targeting the Structural Source of Pain

Intra-annular fibrin injection is a minimally invasive, regenerative procedure designed to seal and support damaged annular tissue — the tough outer wall of the intervertebral disc. It does not involve general anesthesia, spinal implants, or significant surgical trauma. Candidates are evaluated individually based on imaging findings, symptom history, and prior treatment record.

How the Fibrin Procedure Works

The annulus fibrosus (the disc’s outer shell) contains a network of collagen fibers that resist mechanical stress. When this structure tears — whether from acute injury, cumulative loading, or surgical disruption — inflammatory proteins from the disc’s inner nucleus can migrate through the fissure and contact pain-sensitive nerve endings. Standard treatments do not close these tears.

Intra-annular fibrin injection addresses this mechanism directly:

1. Blood draw: A small volume of the patient’s own blood is collected prior to the procedure.
2. Fibrin preparation: The sample is processed to concentrate fibrin, a naturally occurring protein central to the body’s clotting and wound-repair cascade.
3. Image-guided delivery: Under fluoroscopic guidance, the fibrin biologic is precisely deposited within the identified annular tear or tears.
4. Scaffold formation and tissue support: The fibrin acts as a biological scaffold, sealing the tear, reducing inflammatory protein leakage, and creating a structural environment that may support the body’s own tissue repair processes.

Because fibrin is derived from the patient’s own blood, the systemic risk profile differs substantially from synthetic implants or repeated corticosteroid exposure. The procedure is performed on an outpatient basis, and most patients return home the same day.

For a detailed look at how this approach compares with spinal fusion, see our article on biologic disc repair vs. traditional spine surgery.

Fibrin Disc Treatment in the Context of FBSS

One of the most clinically significant aspects of fibrin disc treatment is its potential utility for patients who have already undergone spinal surgery. In published fibrin studies, a meaningful proportion of enrolled patients had a prior surgical history, and many in that subset reported positive outcomes at extended follow-up intervals. Critically, these prior-surgery patients experienced pain reduction on validated scales that persisted well beyond the typical duration of steroid injections.

Key considerations for FBSS candidacy include:

• Evidence of annular disruption on MRI or advanced imaging, representing a viable target for fibrin delivery
• Symptom pattern consistent with discogenic pain rather than primary hardware failure or central sensitization alone
• Absence of active infection, severe instability, or other absolute contraindications
• Adequate disc height to permit image-guided needle access

Not every FBSS patient is a candidate. Our clinical team performs a detailed evaluation before any treatment recommendation is made. In some cases, provocative discography or additional imaging studies help clarify which discs are symptomatic and whether fibrin delivery is technically feasible.

For patients who have already experienced one surgical failure, the appeal of a minimally invasive, non-fusion approach is substantial. Learn more in our dedicated resource: After failed back surgery: is biologic disc repair your next step?

Potential Benefits of Intra-Annular Fibrin Injection for FBSS Patients

Based on available clinical data and our clinical team’s experience evaluating FBSS candidates, the fibrin procedure may offer several advantages over additional surgery — though individual outcomes vary and no result is guaranteed.

• Structural repair rather than symptom masking: The fibrin biologic targets the annular tear itself, not simply the inflammatory response downstream of it.
• Minimally invasive profile: Outpatient delivery, no general anesthesia, and no permanent implants mean the risk landscape is substantially different from revision surgery.
• Potential durability: Published follow-up data extending to two years or beyond suggest that pain relief in responding patients may be maintained over time — though durability varies by case.
• Applicable after prior surgery: Unlike many regenerative approaches that exclude post-surgical patients, fibrin disc treatment has been evaluated in patients with prior spine procedures, including fusion and discectomy.
• Reduced dependency on ongoing pain management: For patients whose pain management currently relies on repeated injections or long-term medications, reducing structural pain generation may help decrease that reliance — an outcome that is evaluated individually.

For veterans specifically, these characteristics align with the desire to reduce medication burden, maintain independence, and avoid additional surgical recovery periods that interfere with family and professional life.

Expert Take

When we evaluate a veteran with FBSS, we are not simply asking whether fibrin can be delivered to the disc. We are asking whether the residual pain generator is structurally accessible, whether the disc environment is compatible with fibrin scaffold formation, and whether the patient’s overall health and prior surgical anatomy allow for a safe procedure. That individualized assessment is what separates a well-matched candidate from someone who would be better served by a different approach.

What a Candidacy Evaluation at Valor Spine Involves

Determining whether intra-annular fibrin injection is appropriate for a given patient requires a structured diagnostic process. Our clinical team’s evaluation typically includes:

• Comprehensive pain and surgical history: We review the timeline of symptoms, prior procedures, what provided relief, and what did not — including duration and nature of any post-surgical improvements.
• Physical and neurological examination: Range of motion, neurological testing, and provocative maneuvers help map the pain distribution and rule out non-discogenic contributors.
• Advanced imaging review: MRI interpretation focused on annular integrity, disc height, signal change, and the presence of endplate pathology. Prior operative reports are reviewed alongside current imaging to assess surgical anatomy changes.
• Supplemental diagnostics when indicated: In selected cases, provocative discography may be considered to confirm symptomatic disc levels before treatment planning proceeds.
• Goals-of-care conversation: We discuss what improvement in function would mean for each individual — whether that is returning to work, reducing medication dependence, or resuming physical activity — and frame realistic expectations accordingly.

This process is not a formality. It is the mechanism by which we protect patients from undergoing a procedure that is unlikely to benefit them, while identifying those for whom the fibrin procedure represents a clinically sound option.

If you are unsure whether you might qualify, our self-assessment resource may help: Am I a candidate for biologic disc repair?

Veterans and Access to Non-Surgical Spine Care

One barrier veterans often face is navigating the intersection of VA benefits, private insurance, and access to advanced non-surgical procedures. Our team works with patients to clarify coverage options and community care pathways. For veterans exploring how to access care outside the VA system, our resource on accessing care and financial considerations for veterans provides practical guidance.

Additionally, veterans evaluating whether to pursue biologic disc repair before considering repeat surgery may find value in: 5 things to know about avoiding failed back surgery with regenerative disc repair first.

Taking the Next Step

Failed Back Surgery Syndrome does not automatically mean that all treatment options have been exhausted. For patients whose ongoing pain stems from persistent or newly identified annular disc damage, intra-annular fibrin injection may represent a meaningful next step — one that avoids additional surgical risk and targets the structural source of pain rather than managing its downstream effects.

Our clinical team evaluates each patient individually. We do not offer blanket recommendations, and we do not promise outcomes that depend on factors unique to each case. What we do offer is a thorough, evidence-informed assessment and a frank conversation about whether fibrin disc treatment is likely to be beneficial in your specific situation.

If you are living with persistent pain after spinal surgery — or if you are a veteran whose disc-related pain has not responded to conservative care — we invite you to schedule a consultation with our team to determine whether biologic disc repair may be appropriate for you.

For further reading, explore our detailed guide on avoiding failed back surgery by considering regenerative disc repair first, or review the evidence behind emerging evidence for biologic disc repair.